Share ownership Shenyang Xingqi Pharmaceutical Co.,Ltd.
Equities
300573
CNE100002DV1
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.19 CNY | -0.91% |
|
-1.55% | -4.41% |
| 03-12 | Shenyang Xingqi Pharmaceutical Doses First Patient in Eye Drop Trial | MT |
| 03-10 | Xingqi Pharmaceutical Completes Establishment of New Subsidiary | MT |
Share class: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 175,249,247 | 119,234,614 ( 68.04 %) | 0 | 68.04 % |
Major shareholders: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| Name | Equities | % | Valuation |
|---|---|---|---|
China Southern Asset Management Co., Ltd.
1.055
%
| 1,988,459 | 1.055 % | 19 M ¥ |
China Asset Management Co., Ltd.
0.9342
%
| 1,760,526 | 0.9342 % | 17 M ¥ |
Franklin Templeton Sealand Fund Management Co., Ltd.
0.6301
%
| 1,187,337 | 0.6301 % | 11 M ¥ |
Fullgoal Fund Management Co., Ltd.
0.437
%
| 823,442 | 0.437 % | 8 M ¥ |
0.4077
%
| 768,320 | 0.4077 % | 7 M ¥ |
China Merchants Fund Management Co., Ltd.
0.3709
%
| 699,032 | 0.3709 % | 7 M ¥ |
Golden Trust Sinopac Fund Management Co., Ltd.
0.3673
%
| 692,140 | 0.3673 % | 7 M ¥ |
Zhong Ou Asset Management Co., Ltd
0.3544
%
| 667,917 | 0.3544 % | 6 M ¥ |
Huatai-PineBridge Fund Management Co., Ltd.
0.3281
%
| 618,339 | 0.3281 % | 6 M ¥ |
Chang Xin Asset Management Co., Ltd.
0.2915
%
| 549,340 | 0.2915 % | 5 M ¥ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| Name | Equities | % | Valuation |
|---|---|---|---|
3.8
%
| 1,536,640 | 3.8 % | 15 M ¥ |
Breakdown by shareholder type
| Institutional | 7.16% |
| Individuals | 1.22% |
| Unknown | 91.62% |
Based on 1000 largest holdings
Geographical origin of shareholders
China | 7% |
Individuals
| 1.22% |
United Kingdom | 0.13% |
Hong Kong | 0.03% |
Based on 1000 largest holdings
Employees
2,426
Sector
Pharmaceuticals
Calendar
04-22 -
Earnings release - Annual 2025
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















